$0.404600
-0.03-6.99%
At Close: -
$0.434400
0.037.37%
After Hours: 9:01 AM EDT
15 minutes delayed
Ensysce Biosciences reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Ensysce Biosciences using advanced sorting and filters.
Get Alert | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
ENSC | Ensysce Biosciences | -$0.98 | -$0.39 | — | — | $490.47K | $300.00K | — | — | 08/09/2024 | Get Alert |
ENSC | Ensysce Biosciences | -$2.08 | -$0.93 | -$0.55 | 40.86% | $789.63K | $400.00K | $305.72K | -23.57% | 05/13/2024 | Get Alert |
ENSC | Ensysce Biosciences | -$18.24 | -$0.87 | -$1.13 | -29.89% | $1.43M | $390.00K | $515.03K | 32.06% | 03/15/2024 | Get Alert |
ENSC | Ensysce Biosciences | -$61.56 | -$1.06 | -$0.87 | 17.92% | $279.35K | $590.00K | $435.38K | -26.21% | 11/09/2023 | Get Alert |
ENSC | Ensysce Biosciences | -$57.60 | -$2.73 | -$0.98 | 64.10% | $207.47K | $826.67K | $490.47K | -4066.89% | 08/11/2023 | Get Alert |
ENSC | Ensysce Biosciences | -$14.66 | -$10.89 | -$2.08 | 80.90% | $603.10K | $950.00K | $789.63K | -16.88% | 05/15/2023 | Get Alert |
ENSC | Ensysce Biosciences | -$108.00 | -$28.92 | -$18.24 | 36.93% | $1.64M | $1.54M | $1.43M | -6.95% | 03/30/2023 | Get Alert |
ENSC | Ensysce Biosciences | -$170.40 | -$38.40 | -$61.56 | -60.31% | $1.20M | $1.00M | $279.35K | -72.06% | 11/14/2022 | Get Alert |
ENSC | Ensysce Biosciences | -$14.40 | -$40.80 | -$57.60 | -41.18% | $444.52K | $1.00M | $207.47K | -79.25% | 08/11/2022 | Get Alert |
ENSC | Ensysce Biosciences | -$14.40 | — | -$14.40 | — | $250.58K | — | $603.10K | — | 05/12/2022 | Get Alert |
ENSC | Ensysce Biosciences | $2.40 | — | -$108.00 | — | $416.49K | $1.00M | $1.64M | 63.50% | 03/31/2022 | Get Alert |
ENSC | Ensysce Biosciences | $21.60 | — | -$170.40 | — | $827.64K | — | $1.20M | — | 11/15/2021 | Get Alert |
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Mar 2024 | 2024-05-13 | $-0.55 | $-0.93 | 40.9 % |
Dec 2023 | 2024-03-15 | $-1.13 | $-0.87 | -29.9 % |
Sep 2023 | 2023-11-09 | $-0.87 | $-1.06 | 17.9 % |
Jun 2023 | 2023-08-11 | $-0.98 | $-2.73 | 64.1 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Mar 2024 | 2024-05-13 | $305.72K | $400.00K | -23.6 % |
Dec 2023 | 2024-03-15 | $515.03K | $390.00K | 32.1 % |
Sep 2023 | 2023-11-09 | $435.38K | $590.00K | -26.2 % |
Jun 2023 | 2023-08-11 | $490.47K | $826.67K | -4066.9 % |
Ensysce Biosciences (ENSC) is scheduled to report earnings on August 9, 2024. The last reported earnings were for reported on May 13, 2024 for Q1.
The Actual EPS was $-0.55, which beat the estimate of $-0.93.
The Actual Revenue was $305.7K, which missed the estimate of $400K.
Browse earnings estimates, EPS, and revenue on all stocks.